Key facts
- This page summarizes Versant Venture Capital VI, L.P.'s Form 4 filing for Black Diamond Therapeutics, Inc. (BDTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Aug 2024, 16:16.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $6.32 to $6.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Footnote F2
These shares are held of record by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
Footnote F3
These shares are held of record by Versant Voyageurs I, L.P. ("Versant Voyageurs I"). Versant Voyageurs I GP Company ("Versant Voyageurs I GP") is the general partner of Versant Voyageurs I and may be deemed to share voting, investment and dispositive power over the shares held by Versant Voyageurs I. Versant Voyageurs I GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interests therein.
Footnote F4
These shares are held of record by Versant Voyageurs I Parallel, L.P. ("Versant I Parallel"). Versant Voyageurs I GP, L.P. ("Versant Voyageurs I GP LP") is the general partner of Versant I Parallel and may be deemed to share voting, investment and dispositive power over the shares held by Versant I Parallel and disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein.
Footnote F5
These shares are held of record by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP LP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP LP and each may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I. Each of Versant Vantage I GP-GP and Versant Vantage I GP LP disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.